-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Malignant Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Malignant Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Malignant Mesothelioma Drug Details: PRO-1184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Fallopian Tube Cancer Drug Details: PRO-1107 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Adenocarcinoma Of The Gastroesophageal Junction Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Epithelial Ovarian Cancer Drug Details: PRO-1107 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1160 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1160 in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1160 in Mantle Cell Lymphoma Drug Details: PRO-1160 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Fallopian Tube Cancer Drug Details: PRO-1184 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Epithelial Ovarian Cancer Drug Details: PRO-1184 is under...
-
Innovation Ranking
Innovation Ranking – Pro-Dex Inc
Pro-Dex Inc (Pro-Dex) is a medical device company that manufactures and markets surgical devices. The company’s products include motion control, finished medical devices, micro air-motors, plastic injection molding, dental products and torque wrenches. Its dental products comprise DLS handpiece system, oral surgery handpiece and prophy plus. Pro-Dex offers services such as design and technical drafting, electronics and software, mechanical engineering and design, precision machining and assembly, quality and compliance, testing, prototyping and validation, and precision injection molding. It serves healthcare,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1160 in Papillary Renal Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1160 in Papillary Renal Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1160 in Papillary Renal Cell Carcinoma Drug Details: PRO-1160...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1107 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1107 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1107 in Non-Small Cell Lung Cancer Drug Details: PRO-1107...